The global smart pills market was valued at $257 million in 2017, and is expected to reach $650 million by 2025, registering a CAGR of 12.1% from 2018 to 2025

Tuesday, October 23, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 22, 2018 /PRNewswire/ -- Smart Pills Market by Application (Capsule Endoscopy, Patient Monitoring, and Drug Delivery), Target Area (Stomach, Esophagus, Small Intestine, and Large Intestine), Disease Indication (Esophageal Diseases, Small bowel Diseases, Colon Diseases, and Others), and End User (Hospital, Diagnostic Center, and Research Center): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Download the full report: https://www.reportbuyer.com/product/5591586Smart Pills Market Overview :The global smart pills market was valued at $257 million in 2017, and is expected to reach $650
million
by 2025, registering a CAGR of 12.1% from 2018 to 2025. Smart pill is an ingestible capsule with miniaturized micro-electronics. Smart pill is designed to visualize the gastrointestinal tract, thus allowing for the diagnosis and observation of lesions and disease states or conditions. As the capsule travels through the digestive tract, the camera clicks thousands of pictures that are transmitted to a recorder worn by the patient on a belt around the waist. Smart pills are widely being used for the diagnosis of various gastrointestinal disorders such as Barrett's Esophagus, Irritable Bowel Syndrome, GERD (Gastroesophageal reflux disease) and others. In addition, smart pills are also being used for targeted drug delivery and patient monitoring. Smart pills find applications in solving the problem of medication non-adherence and enables the doctor to track the medication consumption patterns of a patient.The key factors driving the market growth include rise in prevalence of gastrointestinal disorders such as ulcers, Crohn's disease, colon cancer and others, favorable reimbursement scenario across the globe, and the preference of a patient toward minimally invasive diagnostic procedures. In addition, benefits offered by the smart pills such as non-invasive diagnostic procedures, controlled/targeted drug delivery, and real-time patient monitoring boost the growth of the market. However, stringent governmental regulations regarding the use of smart pills and high cost associated with them are anticipated to hamper the market growth. On the contrary, technological advancements, such as microprocessors, micro-camera, micro-sensors, and others, are predicted to create lucrative opportunities in the future.The global smart pills market is segmented based on application, target area, disease indication, end user, and region. Based on application, the market is divided into capsule endoscopy, drug delivery, and patient monitoring. Based on target area, the market is classified into esophagus, small intestine, large intestine, and stomach. Based on disease indication, it is classified into Barrett's esophagus, Crohn's disease, small bowel tumor, celiac disease, colon cancer, and others. Based on end user, it is classified into hospital, diagnostic center, and research center. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.Key Benefits for Smart Pills Market :The study provides an in-depth analysis of the smart pills market with the current trends and future estimations to elucidate the imminent investment pockets.A comprehensive analysis of the factors that drive and restrict the market growth is provided.A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.An extensive analysis of the key segments of the industry helps to understand the trends in the smart pills market globally.Key players and their strategies are provided to understand the competitive outlook of the industry.Smart Pills Key Market Segments :By ApplicationCapsule EndoscopyDrug DeliveryPatient MonitoringBy Target AreaEsophagusSmall IntestineLarge IntestineStomachBy Disease IndicationEsophageal DiseasesSmall Bowel DiseasesColon DiseasesOthersBy End UserHospitalDiagnostic CenterResearch InstituteBy RegionNorth AmericaU.S.CanadaMexicoEuropeUKFranceGermanyItalyFranceRussiaRest of EuropeAsia-PacificJapanChinaIndiaSouth KoreaTaiwanAustraliaRest of Asia-PacificLAMEASaudi ArabiaSouth AfricaBrazilTurkeyArgentinaRest of LAMEAKEY MARKET PLAYERSProteus Digital HealthHQ, Inc.CapsoVision, Inc.Medtronic Plc.Olympus CorporationsIntroMedic Co., LtdRF Co., LtdJINSHAN Science & TechnologyCheck CapKoninklijke Philips N.VThe other players in the value chain include (profiles not included in the report)GE HealthcareNOVARTIS AGFujifilm Holdings CorporationBio-Images Drug Delivery (BDD) LimitedQuotient Clinical Ltd.Innovative Devices LLCPENTAX MedicalDownload the full report: https://www.reportbuyer.com/product/5591586 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-global-smart-pills-market-was-valued-at-257-million-in-2017--and-is-expected-to-reach-650-million-by-2025--registering-a-cagr-of-12-1-from-2018-to-2025--300735477.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store